Tatva Chintan Pharma IPO Details

Tatva Chintan Pharma Chem IPOTatva Chintan Pharma Chem IPO description – Tatva Chintan Pharma Chem is a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC). The company is the largest and only commercial manufacturer of SDAs for zeolites in India while also enjoying the second largest position globally. In addition, the company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe.

The company’s products – 138 as of 31 December 2020 – are used across various industries, including the automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavour and fragrances industries. Apart from serving the domestic market, the company exports its products to over 25 countries, including the USA, China, Germany, Japan, South Africa, and the UK. During the nine months ended 31 December 2020, exports of products accounted for 70.7% of its revenue from operations.

Promoters of Tatva Chintan Pharma – Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Shekhar Rasiklal Somani
Tatva Chintan Pharma Chem IPO details
Subscription Dates16 – 20 July 2021
Price BandINR1,073 – 1,083 per share
Fresh issueINR225 crore
Offer For SaleINR275 crore
Total IPO sizeINR500 crore
Minimum bid (lot size)13 shares
Face Value INR10 per share
Retail Allocation35%
Listing OnNSE, BSE

Tatva Chintan Pharma's financial Performance (in INR crore)

 FY2018FY2019FY2020FY2021
Revenue137.3206.8264.6306.3
Expenses118.3180.2217.0245.6
Comprehensive income12.320.537.652.4
Margin (%)9.09.914.217.1

More about Tatva Chintan Pharma Chem IPO

Registrar of Tatva Chintan Pharma IPO

Link Intime India Private Limited C-101, 1st Floor,
247 Park Lal Bahadur Shastri Marg,
Vikhroli (West) Mumbai – 400 083
Phone: +91 22 4918 6200
Fax: +91 22 4918 6195
Email: [email protected]
Website: http://www.linkintime.co.in

Tatva Chintan Pharma Contact Details

Tatva Chintan Pharma Chem Limited
Plot No. 353, Makarpura GIDC,
Vadodara, Gujarat – 390 010
Phone: +91 75748 48533
Email: [email protected]
Website: www.tatvachintan.com

Valuation of Tatva Chintan Pharma (as of FY2021)

Earnings Per Share (EPS): INR26.02
Price/Earnings (PE ratio): 41.24 – 41.62
Return on Net Worth (RONW): 31.49%
Net Asset Value (NAV): INR82.62 per share

Tatva Chintan Pharma IPO GMP Daily Trend

DateTatva Chintan IPO GMPKostakSubject to Sauda
28 July 2021INR1,150
27 July 2021INR1,100
26 July 2021INR1,000INR450INR8,800
23 July 2021INR900INR450INR7,800
22 July 2021INR800INR450INR7,300
21 July 2021INR800INR450INR7,300
20 July 2021INR700INR400INR6,800
19 July 2021INR700INR400INR6,800
17 July 2021INR640INR350INR6,100
16 July 2021INR620INR350INR5,700
15 July 2021INR600INR350INR5,300
14 July 2021INR560INR340INR5,000
13 July 2021INR500INR300INR5,000
12 July 2021INR450INR300INR5,000

Tatva Chintan Pharma IPO Subscription Details

CategoryShares offeredSubscription (no. of times, at 5 PM)
Day 1Day 2Day 3
QIB9,31,9660.511.97185.23
NII6,98,9751.1312.21512.22
Retail16,30,9418.2523.7535.35
     
Total32,61,8824.5115.05180.36

Tatva Chintan Pharma IPO Review - Broker Views

Angel Broking – Subscribe
BP Wealth – Subscribe
Choice Broking – Subscribe
Elite Wealth – Subscribe
Hem Securities – Subscribe
ICICIdirect – Unrated
Investmentz – Subscribe for long term
KR Choksey – Subscribe
Marwadi Financial Services – Subscribe
Mehta Equities – Subscribe
Motilal Oswal – Subscribe
Reliance Securities – Subscribe
Samco Securities – Subscribe with caution
SMC Global Securities – 2.5/5
Ventura Securities – Subscribe

Tatva Chintan Pharma IPO Allotment Status

Tatva Chintan Pharma IPO allotment status isn’t yet available on Link Intime’s website. Once available, click on this link to get allotment status.

Meanwhile, bank debits have started. Check bank statement for removed lien or amount deduction to know allotment status.  

Listing Performance of Tatva Chintan Pharma Chem

IPO Opening Date: 16 July 2021
IPO Closing Date: 20 July 2021
Finalisation of Basis of Allotment: 26 July 2021
Initiation of refunds: 27 July 2021
Transfer of shares to demat accounts: 28 July 2021
Listing Date: 29 July 2021
Opening Price on NSE: INR2,111.85 per share (up 95% from IPO price)
Closing Price on NSE: INR2,312.2 per share (up 113.5% from IPO price)

6 COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Brokerage-free IPO Investing

X